OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106. A total of 76 filers reported holding OLEMA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $172,937 | +1168.3% | 14,003 | +827.4% | 0.00% | – |
| Q2 2023 | $13,635 | +1004.0% | 1,510 | +324.2% | 0.00% | – |
| Q1 2023 | $1,235 | -87.7% | 356 | -91.3% | 0.00% | – |
| Q4 2022 | $10,015 | +43.1% | 4,088 | +68.2% | 0.00% | – |
| Q3 2022 | $7,000 | – | 2,431 | +9250.0% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 26 | -80.0% | 0.00% | – |
| Q4 2021 | $1,000 | -95.2% | 130 | -79.6% | 0.00% | – |
| Q1 2021 | $21,000 | -99.2% | 636 | -98.8% | 0.00% | -100.0% |
| Q4 2020 | $2,560,000 | – | 53,253 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 3,743,875 | $15,238,000 | 2.80% |
| Fairmount Funds Management LLC | 2,669,300 | $10,864,000 | 2.49% |
| BVF INC/IL | 7,611,503 | $30,979,000 | 1.50% |
| Vivo Capital, LLC | 1,689,515 | $6,876,000 | 0.69% |
| Cormorant Asset Management, LP | 2,082,000 | $8,474,000 | 0.64% |
| Newtyn Management, LLC | 500,000 | $2,035,000 | 0.39% |
| Kynam Capital Management, LP | 249,229 | $1,014,000 | 0.26% |
| Monaco Asset Management SAM | 130,000 | $529,000 | 0.23% |
| TANG CAPITAL MANAGEMENT LLC | 318,926 | $1,298,000 | 0.20% |
| Artal Group S.A. | 260,500 | $1,060,000 | 0.06% |